Related stories
Eli Lilly Raises 2026 Sales Outlook on Strong Mounjaro, Zepbound Demand
Eli Lilly raised its full-year sales outlook after third-quarter results topped expectations. Revenue rose 38.6% year over year to $24.4 billion, beating consensus by $1.78 billion
M impact | EARNINGS | Oct 29, 2026, 03:13 PM UTC
Microsoft Guides for Q2 Revenue of $96 Billion to $97.1 Billion
Microsoft expects revenue and Azure growth to accelerate in the December quarter as delayed AI infrastructure spending shifts into the fiscal year's second half. Its Q2 revenue gui
M impact | EQUITY | Oct 29, 2026, 03:11 PM UTC
Repsol Hikes Buybacks and Guidance After Record Profit
Spain’s Repsol increased buybacks and guidance after reporting its highest profit ever.
M impact | EARNINGS | Oct 29, 2026, 03:05 PM UTC
Microsoft shares reverse course, down 1.3%
M impact | EQUITY | Oct 29, 2026, 03:05 PM UTC
Italgas 9M Adjusted Net Profit Rises 18% to €585.5 Million
M impact | EARNINGS | Oct 29, 2026, 03:03 PM UTC
O'Reilly Automotive Raises Full-Year Comparable Store Sales Guidance
O'Reilly Automotive cited robust third-quarter sales and a favorable impact from tariff refunds for the upward revision.
M impact | EARNINGS | Oct 29, 2026, 03:03 PM UTC